Severe methemoglobinemia following intravenous lidocaine administration during coronary artery bypass surgery: The use of methylene blue and extracorporeal membrane oxygenator Koroner arter baypas ameliyatı sırasında intravenöz lidokain uygulamasını takiben şiddetli methemoglobinemi: Metilen mavisi ve ekstrakorporeal membran oksijenatör kullanımı

Creative Commons License

KAYA K., Mungan U.

Turkish Journal of Thoracic and Cardiovascular Surgery, cilt.29, sa.4, ss.546-548, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5606/tgkdc.dergisi.2021.21982
  • Dergi Adı: Turkish Journal of Thoracic and Cardiovascular Surgery
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier
  • Sayfa Sayıları: ss.546-548
  • Anahtar Kelimeler: Extracorporeal membrane oxygenator, lidocaine, methemoglobinemia, methylene blue
  • Lokman Hekim Üniversitesi Adresli: Evet

Özet

© 2021 All right reserved by the Turkish Society of Cardiovascular Surgery. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes (http://creativecommons.org/licenses/by-nc/4.0/).A 63-year-old male patient underwent coronary artery bypass surgery under cardiopulmonary bypass. Preoperative test results were all normal. During surgery, sudden methemoglobinemia developed after the intravenous administration of lidocaine which was used to prevent arrhythmias. In the intensive care unit, methylene blue was given to the patient and an extracorporeal membrane oxygenator was used to correct deep hypotension and worsening hemodynamic parameters. However, the patient died from multiorgan failure secondary to hypoxia. In conclusion, many factors may play a role in the etiology of methemoglobinemia. Treatment options are limited. Methylene blue is used as an effective method in the treatment. Lidocaine is one of the most common drugs used in the practice of cardiology and cardiovascular surgery. Therefore, the possibility of developing methemoglobinemia should be always kept in mind.